Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.42 |
| ▸ | CD38 | P28907 | 15/20 | 0.42 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.38 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28273966 | 0.85 | DYRK1A (0.45) | DYRK1ACD38DYRK2DYRK1BHDAC4 | |
| SCHEMBL32687454 | 0.80 | DYRK1A (0.41) | DYRK1ACD38DYRK2DYRK1BHDAC4 | |
| SCHEMBL30987723 | 0.75 | SLC22A12 (0.47) | DYRK1ACD38HDAC4CHEK1CHEK2 | |
| SCHEMBL27272888 | 0.75 | SLC22A12 (0.47) | DYRK1ACD38HDAC4CHEK1CHEK2 | |
| SCHEMBL17643727 | 0.74 | CD38 (0.53) | DYRK1ACD38DYRK2DYRK1BHDAC4 | |
| SCHEMBL32671911 | 0.74 | CD38 (0.53) | DYRK1ACD38DYRK2DYRK1BHDAC4 | |
| SCHEMBL26260195 | 0.74 | DYRK1A (0.49) | DYRK1ACD38DYRK2DYRK1BPRMT5 | |
| SCHEMBL7915410 | 0.74 | CD38 (0.49) | DYRK1ACD38DYRK2DYRK1BHDAC4 | |
| SCHEMBL28279469 | 0.74 | PIK3CD (0.43) | DYRK1ACD38HDAC4PRMT5WDR77 | |
| SCHEMBL1864798 | 0.73 | CYP11B1 (0.43) | DYRK1ACD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, MCL1 | DYRK1A 1128/4885CD38 2044/4885DYRK2 1077/4885 |
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | KRAS, MYC, NRAS | DYRK1A 3010/4885CD38 1590/4885DYRK2 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.